Marina Šagud - Concepedia

Author

Marina Šagud

Also Known As

Klinika za psihijatriju i psihološku medicinu, Klinički bolnički centar Zagreb, M Sagud, M Šagud, M. Sagud, M. Šagud, Marina SAGUD, Marina Sagud, Marina Šagud, Milena Skočić Hanžek, S. Levaj

218

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

University Hospital Centre Zagreb University of Zagreb Rudjer Boskovic Institute University of Osijek Klinika za psihijatriju Vrapče

MŠ

About

Marina Šagud is an author at University Hospital Centre Zagreb specializing in medicine, psychiatry, and psychopathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	35	1.4K
2	Social Sciences	16	21	895
3	Endocrinology	3	3	153
4	Health Sciences	1	1	58
5	Epidemiology	1	1	27

Marina Šagud

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels José de León, Georgios Schoretsanitis, Robert L. Smith, Pharmacopsychiatry	2021	234
Smoking and schizophrenia. Marina Šagud, Alma Mihaljević-Peleš, Dorotea Mück‐Šeler, PubMed Schizophrenic PatientsNeuropsychologyPsychotropic MedicationPsychopharmacologyPsychology	2009	117
Depression: Biological markers and treatment Gordana Nedić Erjavec, Marina Šagud, Matea Nikolac Perković, Progress in Neuro-Psychopharmacology and Biological Psychiatry PsychopathologyPsychiatryMood SymptomBiological MarkersDepression	2020	112
Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women Dorotea Mück‐Šeler, Nela Pivac, Maja Mustapić, Psychiatry Research Stress HormonePsychiatryPlasma ProlactinNeuroendocrine DisorderDepression	2004	101
MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression Alma Mihaljević Peleš, Nada Božina, Marina Šagud, Progress in Neuro-Psychopharmacology and Biological Psychiatry PsychiatryPsychotropic MedicationMdr1 Gene PolymorphismPsychiatric GeneticsPharmacology	2008	96
The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression Dorotea Mück‐Šeler, Nela Pivac, Marina Šagud, Progress in Neuro-Psychopharmacology and Biological Psychiatry PsychiatryMood SymptomMedicinePsychotropic MedicationSubcortical Ischemic Depression	2002	76
Olanzapine in the treatment‐resistant, combat‐related PTSD – a series of case reports Miro Jakovljević, Marina Šagud, Alma Mihaljević-Peleš Acta Psychiatrica Scandinavica	2003	69
Cognitive deficit in schizophrenia: an overview. Alma Mihaljević-Peleš, Maja Bajs Janović, Marina Šagud, PubMed NeuropsychologyBrain FunctionNeuropsychiatryCognitive DeficitSocial Sciences	2019	68
Lipid levels in female patients with affective disorders Marina Šagud, Alma Mihaljević-Peleš, Nela Pivac, Psychiatry Research Metabolic SyndromeLipid DisorderHealth SciencesPsychiatryLipid Disorders	2009	58
Effects of Sertraline Treatment on Plasma Cortisol, Prolactin and Thyroid Hormones in Female Depressed Patients Marina Šagud, Nela Pivac, Dorotea Mück‐Šeler, Neuropsychobiology Stress HormonePsychiatryMood SymptomPharmacologySertraline Treatment	2002	58

Page 1